Clinical Trial

Inflammatory Biomarkers as Predictors of PONV Following Pediatric Orchiopexy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 9, 2025 (before its estimated March 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
Orchiopexy is a common surgical procedure for the treatment of cryptorchidism in the pediatric population, with a high incidence of postoperative nausea and vomiting (PONV). Recent evidence suggests that systemic inflammation may contribute to PONV pathogenesis, and preoperative inflammatory biomarkers such as NLR, PLR, SII, MLR, and SIRI could serve as predictive indicators. This prospective observational study aims to evaluate the relationship between these biomarkers and PONV incidence in children undergoing orchiopexy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-22.
Status change: Not Yet Recruiting → Recruiting 2025-09-08
Trial Details
NCT Number NCT07148063
Lead Sponsor Diskapi Yildirim Beyazit Education and Research Hospital
Conditions Pediatric Anesthesia, Postoperative Nausea and Vomiting (PONV), Inflammatory Biomarkers
Enrollment 170 participants
Start Date 2025-09-08
Primary Completion 2026-03-13 (estimated)
Study Completion 2026-03-27 (estimated)
Updated on ClinicalTrials.gov 2025-09-09